First Time Loading...
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48%
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

5.1B
+4%
Assets
Growth Rates:
1 Year
-2%
3 Years
+13%
5 Years
-6%
7 Years
+59%
10 Years
+64%
1.6B
+4%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
+12%
5 Years
-51%
7 Years
+8%
10 Years
-19%
3.5B
+4%
Equity
Growth Rates:
1 Year
-2%
3 Years
+14%
5 Years
+65%
7 Years
+104%
10 Years
+210%

Balance Sheet Decomposition
Vifor Pharma AG

5.1B
Assets
1.6B
Liabilities
5.1B
Assets
1.6B
Liabilities
Current Assets 1.9B
Cash & Short-Term Investments 994.5m
Receivables 442.7m
Other Current Assets 441.4m
Non-Current Assets 3.2B
Long-Term Investments 482.2m
PP&E 187.2m
Intangibles 2.4B
Other Non-Current Assets 165.6m
Current Liabilities 981.3m
Accounts Payable 163.1m
Accrued Liabilities 203.6m
Other Current Liabilities 614.6m
Non-Current Liabilities 628.4m
Long-Term Debt 117m
Other Non-Current Liabilities 511.4m

Balance Sheet
Vifor Pharma AG

Rotate your device to view
Balance Sheet
Currency: CHF
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
348
216
239
422
181
425
400
545
730
994
Cash Equivalents
348
216
239
422
181
425
400
545
730
994
Short-Term Investments
7
0
0
0
2
2
2
0
8
1
Total Receivables
544
549
635
582
704
412
523
479
492
443
Accounts Receivables
497
510
507
544
699
350
411
414
411
374
Other Receivables
47
39
127
38
4
62
112
65
81
69
Inventory
366
353
376
384
433
232
282
349
340
347
Other Current Assets
66
85
53
34
70
23
41
34
39
94
Total Current Assets
1 331
1 203
1 302
1 422
1 389
1 094
1 249
1 407
1 609
1 879
PP&E Net
438
441
441
450
479
242
270
347
302
187
PP&E Gross
438
441
441
450
0
242
270
347
302
187
Accumulated Depreciation
344
390
390
476
0
239
271
298
335
243
Intangible Assets
200
195
187
513
3 395
1 548
1 582
1 493
1 488
1 401
Goodwill
1 052
1 066
1 066
1 089
0
1 104
1 094
1 092
967
986
Long-Term Investments
105
143
147
140
131
122
212
514
741
483
Other Long-Term Assets
21
21
33
26
34
18
89
82
105
166
Other Assets
1 052
1 066
1 066
1 089
0
1 104
1 094
1 092
967
986
Total Assets
3 147
N/A
3 069
-2%
3 208
+5%
3 640
+13%
5 427
+49%
4 126
-24%
4 496
+9%
4 934
+10%
5 212
+6%
5 100
-2%
Liabilities
Accounts Payable
338
342
0
365
514
174
156
108
162
163
Accrued Liabilities
166
193
135
165
235
224
240
321
249
204
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
140
92
29
138
1 829
8
101
17
23
477
Other Current Liabilities
277
124
174
137
62
183
97
95
110
138
Total Current Liabilities
920
750
685
804
2 640
589
594
541
544
981
Long-Term Debt
646
573
568
494
275
100
464
599
595
110
Deferred Income Tax
74
74
81
86
150
42
34
20
31
24
Minority Interest
32
49
38
97
177
259
313
418
448
479
Other Liabilities
129
117
125
279
67
63
38
38
24
15
Total Liabilities
1 801
N/A
1 564
-13%
1 496
-4%
1 761
+18%
3 309
+88%
1 053
-68%
1 443
+37%
1 617
+12%
1 642
+2%
1 610
-2%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
1 459
1 637
1 828
2 026
2 201
3 226
3 251
3 519
3 863
3 750
Unrealized Security Profit/Loss
8
4
5
1
16
20
1
1
4
1
Treasury Stock
11
16
17
22
24
18
18
14
19
10
Other Equity
95
112
94
124
76
156
182
188
279
252
Total Equity
1 346
N/A
1 506
+12%
1 712
+14%
1 879
+10%
2 118
+13%
3 073
+45%
3 052
-1%
3 318
+9%
3 570
+8%
3 490
-2%
Total Liabilities & Equity
3 147
N/A
3 069
-2%
3 208
+5%
3 640
+13%
5 427
+49%
4 126
-24%
4 496
+9%
4 934
+10%
5 212
+6%
5 100
-2%
Shares Outstanding
Common Shares Outstanding
65
65
65
65
65
65
65
65
65
65

See Also

Summary
VIFN intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIFN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIFN stock valuation using valuation multiples.
Wall Street Estimates
VIFN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIFN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.